Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis

Abstract Background Whether pioglitazone may affect breast cancer risk in female diabetes patients is not conclusive and has not been investigated in the Asian populations. Methods The reimbursement database of Taiwan’s National Health Insurance was used to enroll an unmatched cohort and a propensit...

Full description

Bibliographic Details
Main Author: Chin-Hsiao Tseng
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-022-09660-8